Biogen | BIIB - Ebitda





Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Amgen USD 3.86B 1.28B 2026-03
Bayer EUR 2.14B 2.31B 2026-06
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 5.09B 842M 2026-06
Eli Lilly USD 12.99B 2.7B 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sanofi EUR 2.72B 2.94B 2026-03
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06